Sarcoidosis: a clinical overview from symptoms to diagnosis

P Sève, Y Pacheco, F Durupt, Y Jamilloux… - Cells, 2021 - mdpi.com
Sarcoidosis is a multi-system disease of unknown etiology characterized by the formation of
granulomas in various organs. It affects people of all ethnic backgrounds and occurs at any …

Refractory sarcoidosis: a review

T El Jammal, Y Jamilloux… - … and clinical risk …, 2020 - Taylor & Francis
Sarcoidosis is a multi-system disease of unknown etiology characterized by granuloma
formation in various organs (especially lung and mediastinohilar lymph nodes). In more than …

Extrapulmonary manifestations of sarcoidosis

DA Rao, PF Dellaripa - Rheumatic Disease Clinics, 2013 - rheumatic.theclinics.com
Sarcoidosis is a systemic disorder characterized by the aberrant development of
granulomas within various organs in the body. The lungs are involved in 90% of patients …

Management of extrapulmonary sarcoidosis: challenges and solutions

K Al-Kofahi, P Korsten, C Ascoli… - … and clinical risk …, 2016 - Taylor & Francis
Background Sarcoidosis is a chronic multisystem disease of unknown etiology characterized
by noncaseating granulomas that most often involves the lungs, but frequently has …

Current and emerging pharmacological treatments for sarcoidosis: a review

SH Beegle, K Barba, R Gobunsuy… - Drug Design …, 2013 - Taylor & Francis
The treatment of sarcoidosis is not standardized. Because sarcoidosis may never cause
significant symptoms or organ dysfunction, treatment is not mandatory. When treatment is …

A review of the musculoskeletal manifestations of sarcoidosis

K Bechman, D Christidis, S Walsh, SS Birring… - …, 2018 - academic.oup.com
Sarcoidosis is a systemic disease of unknown aetiology that is characterized by
granulomatous inflammation that can develop in almost any organ system. Musculoskeletal …

Sarcoidosis and autoimmunity

M Song, M Manansala, PJ Parmar… - Current Opinion in …, 2021 - journals.lww.com
Advancements in the understanding of sarcoidosis support its consideration as an
autoimmune disease. Sarcoidosis patients carry a higher risk of comorbid autoimmune …

Twenty-year reflection on the impact of World Trade Center exposure on pulmonary outcomes in Fire Department of the City of New York (FDNY) rescue and recovery …

KL Cleven, C Rosenzvit, A Nolan, R Zeig-Owens… - Lung, 2021 - Springer
After the terrorist attacks on September 11, 2001 (9/11), many rescue/recovery workers
developed respiratory symptoms and pulmonary diseases due to their extensive World …

Refractory pulmonary sarcoidosis: proposal of a definition and recommendations for the diagnostic and therapeutic approach

P Korsten, K Strohmayer, RP Baughman… - Clinical pulmonary …, 2016 - journals.lww.com
Patients with sarcoidosis undergo spontaneous remission or may be effectively controlled
with glucocorticoids alone in many cases. Progressive and refractory pulmonary sarcoidoisis …

Challenges in the diagnosis and treatment of neurosarcoidosis

C Tana, S Wegener, E Borys, S Pambuccian… - Annals of …, 2015 - Taylor & Francis
The diagnosis and treatment of neurosarcoidosis can be very challenging for several
reasons. It affects clinically 5%–10% of sarcoidosis patients, but can be found in up to 25 …